MARKER FOR THE FORECAST OF THE RESPONSE TO THERAPY BZW. THE SURVIVAL RATE OF BREAST CANCER PATIENTS

摘要

The present invention relates to modified and genomic sequences, to oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genomic DNA, as well as to a method for predicting the disease free survival and/or response of a subject with a cell proliferative disorder of the breast tissues, to endocrine treatment.